N-methyl-N-(1-phenyl-2-(1-pyrrolidinyl)ethyl)-2-aminophenylacetamide derivatives agonists for the κ opioid receptor
US-11241415-B2 · Feb 8, 2022 · US
Singh Devendrapratap is listed as an inventor on 9 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Singh Devendrapratap |
| Total patents | 9 |
| First publication | Jun 27, 2017 |
| Latest publication | Feb 8, 2022 |
Publications ranked by popularity score, then publication date.
US-11241415-B2 · Feb 8, 2022 · US
US-10865186-B2 · Dec 15, 2020 · US
US-2019269652-A1 · Sep 5, 2019 · US
US-10322107-B2 · Jun 18, 2019 · US
US-2018362468-A1 · Dec 20, 2018 · US
US-10081602-B2 · Sep 25, 2018 · US
US-2017368029-A1 · Dec 28, 2017 · US
US-2017253565-A1 · Sep 7, 2017 · US
US-9688638-B2 · Jun 27, 2017 · US
Latest publications not already listed above.
No data yet.
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Nektar Therapeutics | 9 |
| Nektar Therapeutics (India) Pvt Ltd | 1 |
| Nektar Therapeutics (Incorporated Under The Laws Of Delaware And Domiclled In The State Of Californi | 1 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P25/04 | 9 |
| C07D513/08 | 5 |
| C07D221/26 | 5 |
| C07D401/12 | 5 |
| A61P43/00 | 4 |